These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26303765)

  • 1. Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings.
    Birnbaum GD; Birnbaum I; Ye Y; Birnbaum Y
    Cardiovasc Drugs Ther; 2015; 29(5):461-7. PubMed ID: 26303765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
    Ye Y; Perez-Polo JR; Birnbaum Y
    Ann N Y Acad Sci; 2010 Oct; 1207():76-82. PubMed ID: 20955429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Birnbaum Y; Birnbaum GD; Birnbaum I; Nylander S; Ye Y
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):539-550. PubMed ID: 27830382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin mediated protection of the ischemic myocardium.
    Wright DG; Lefer DJ
    Vascul Pharmacol; 2005; 42(5-6):265-70. PubMed ID: 15922259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
    Ke D; Fang J; Fan L; Chen Z; Chen L
    Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
    Ye Y; Long B; Qian J; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):391-9. PubMed ID: 20640495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and the response to myocardial injury.
    Scalia R
    Am J Cardiovasc Drugs; 2005; 5(3):163-70. PubMed ID: 15901204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
    Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection in heart surgery.
    Mentzer RM
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):290-7. PubMed ID: 21821531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals.
    Chen M; Li H; Wang Y
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):320-4. PubMed ID: 23714773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
    Bai Y; Muqier ; Murakami H; Iwasa M; Sumi S; Yamada Y; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Uno B; Minatoguchi S
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):658-65. PubMed ID: 21679220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.
    Vilahur G; Casani L; Peña E; Juan-Babot O; Mendieta G; Crespo J; Badimon L
    Int J Cardiol; 2014 Aug; 175(3):528-38. PubMed ID: 25023790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?
    Kassimis G; Davlouros P; Patel N; De Maria G; Kallistratos MS; Kharbanda RK; Manolis AJ; Alexopoulos D; Banning AP
    Cardiovasc Drugs Ther; 2015; 29(5):481-93. PubMed ID: 26150100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
    Figueredo VM; Okusa C; Kaneda K; Inamura Y; Miyamae M
    Int J Cardiol; 2014 Oct; 176(3):822-7. PubMed ID: 25156855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase.
    Gross ER; Hsu AK; Gross GJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):185-91. PubMed ID: 14993258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do We Really Need Aspirin Loading for STEMI?
    Ye R; Jneid H; Alam M; Uretsky BF; Atar D; Kitakaze M; Davidson SM; Yellon DM; Birnbaum Y
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1221-1238. PubMed ID: 35171384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
    Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
    Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.